To deliver clinical tools that provide actionable information in the acute care setting resulting in better care for patients and lower overall medical costs while creating value for our investors and an inspiring work environment for our team.
We seek to transform the way clinicians manage coagulation
dysfunctions by providing comprehensive, timely information on coagulation status at the point of care.
We have developed a next-generation near patient diagnostic platform that provides actionable
information to guide the management of major bleeding and thrombosis enabling clinicians to choose the right treatment in the right time frame, dramatically improving outcomes.
Our innovative _in vitro_ diagnostic platform characterizes
hemostasis – the balance between bleeding and clotting – in avariety of acute care clinical settings.
